The New Science Of Three-Parent Babies
By Tom Ashbrook,
NPR On Point
| 02. 26. 2014
[With CGS's Marcy Darnovsky]
Day two today of F.D.A. hearings on what you may have seen described in headlines as “three-parent babies.” The genetic material of three adults combined to make one healthy baby. Mom’s nuclear D.N.A., dad’s sperm, and mitochondrial D.N.A. from a donor, to avoid inheritable disease. Backers say this reproductive technology will spare families from passing down suffering. Maybe extend fertility for older moms. Critics say this is the gateway to genetically modified human beings, high-tech eugenics, dystopia. This hour On Point: science, ethics, reproduction, and D.N.A. times three.
– Tom Ashbrook
Guests
Dina Fine Maron, associate editor at Scientific American. (@Dina_Maron)
Stefani Bush, singer, blogger and patient advocate. (@HopeRisingMusic)
Marcy Darnovsky, executive director of the Center for Genetics and Society.
Dr. James Grifo, program director of New York University’s Fertility Center.
From Tom’s Reading List
Scientific American: Making Babies with 3 Genetic Parents Gets FDA Hearing — “Reproductive technologies that marry DNA from three individuals will receive a trial in the court of public opinion this week. Such technologies may hold promise for averting certain genetically...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
